Delivery Order SPE2DB20D1004-SPE2DB22FF1Q9
Award Date
1/26/22
Potential Completion Date
1/27/22
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, provides pharmaceutical products and medical supplies to support military healthcare programs globally. The specific Delivery Order awarded is for Micardis HCT 80-25 mg tablets, a cardiovascular medication, with a ceiling value...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a pharmaceutical product. The $13,607.57 delivery order contract has a performance period through May 7, 2024 and utilizes a firm fixed price pricing type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D1004|SPE2DB24FF1M4) valued at $2,762.23 for the supply of Micardis HCT 80-25 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 4, 2024. The contract is a firm fixed-price delivery order, and no set-aside designation was used. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $6,183.14 firm fixed-price delivery order for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S. The award, issued by the Defense Logistics Agency (DLA), has an ultimate completion date of November 23, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,877.99 delivery order contract is for the supply of Micardis HCT 40-12.5 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) under contract number SPE2DB20D2104|SPE2DB22FS44Y. The $2,645.04 firm fixed-price delivery order is for the supply of Micardis HCT 40-12.5 mg tablets. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $1,556.64 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical division. The award is for the supply of Micardis HCT 80-25 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,530.94 under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is for Micardis HCT...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,224.79 delivery order contract is a firm fixed-price agreement for the supply of 4563018964 units of Micardis HCT 80-25 mg tablets. The contract has an ultimate completion date of December 7, 2023 and was awarded on December 6, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The DO, valued at $2,246.82, is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a pharmaceutical product. The IDC, valued at up to $999,999,999.00, enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...